Prevalence of antiphospholipid antibodies in post-COVID and vaccinated individuals
OBJECTIVE: The outbreak of COVID-19 resulted mainly in respiratory disease; however, apart from that, the infection was presented with random systemic thromboembolic events. This study aimed to measure the serum concentration of antiphospholipid antibodies (IgM/IgG) in post-COVID and vaccinated indi...
Saved in:
| Main Authors: | S. Al-Rustum, T. Kobulashvili, P. Sharma, S. Habeebulla, L. Bakhtadze |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2024-03-01
|
| Series: | Infectious Diseases and Tropical Medicine |
| Subjects: | |
| Online Access: | https://www.infectiousjournal.com/wp-content/uploads/sites/6/2024/03/e1370.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiphospholipid Antibodies and COVID‐19: A Systematic Review of Clinical Implications
by: Tahereh Sabaghian, et al.
Published: (2025-02-01) -
Infection-Triggered Antiphospholipid Syndrome: A Critical Overview
by: Smiyan S, et al.
Published: (2025-08-01) -
Catastrophic antiphospholipid COVID-19 syndrome
by: Yu. S. Polushin, et al.
Published: (2021-03-01) -
Improving diagnosis in patients with obstetric antiphospholipid syndrome through the evaluation of non‐criteria antibodies
by: Daniel Álvarez, et al.
Published: (2024-01-01) -
Antiphospholipid antibodies during acute COVID-19 are not associated with long COVID: findings from a retrospective cohort study
by: Robin Arcani, et al.
Published: (2025-08-01)